Anti-TInnus is a hearing offer tracked inside Daily Intel — 1 VSL available to members.
Anti-TInnus appears to compete in the hearing-health vertical, specifically around tinnitus and ear-ringing education. It also borrows from senior wellness and cognitive-risk framing in its positioning.
Based on the available member assets, the offer is primarily represented by a VSL, which is commonly paired with native ads, Facebook ads, or YouTube-style advertorial funnels. No specific historical scaling channel is confirmed from the provided asset count.
The member library lists 1 VSL variant for Anti-TInnus and 0 ad variants. That makes the offer more useful for studying the sales narrative than for comparing creative iterations.
The VSL appears to lead with tinnitus as an early warning signal rather than a simple aging nuisance. It uses concern around hearing symptoms and possible broader health implications as the main hook.
Media buyers would typically compare it against other tinnitus, hearing-support, and senior ear-health supplement offers. Comparable research sets may also include cognitive-wellness offers that use aging-related fear framing.
Audifort is a hearing offer tracked inside Daily Intel — 4 VSL variants available to members.
SonusZen is a hearing offer tracked inside Daily Intel — 2 VSL variants available to members.
Tinitrol is a hearing offer tracked inside Daily Intel — 2 VSL variants available to members.
Tinnitusfix is a hearing offer tracked inside Daily Intel — 2 VSL variants available to members.
Echoxen is a hearing offer tracked inside Daily Intel — 2 VSL variants available to members.
Audizen is a hearing offer tracked inside Daily Intel — 1 VSL available to members.
Beetroot+ is a hearing offer tracked inside Daily Intel — 1 VSL available to members.
Tinnitrol is a hearing offer tracked inside Daily Intel — 1 VSL available to members.